Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I suppose it is possible ...

I agree, just not sure why they would want to expedite the process? Why not wait until they are accused of infringing the ‘386, cite Prior Art and prolong the process even farther. IMO, the good thing here about PUBPAT’s claim is that if the Patent Office reexamines and validates the ‘336, than the process has actually been expedited in our favor. I am not an attorney here so don’t understand all the strategy taking place. I also believe the fact PUBPAT got involved might just give us a hint as to what could be out there in the way of revenue for the MMP. All just MVHO.

<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /> 

GLTAL

Share
New Message
Please login to post a reply